Diming Wang
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinicopathological analysis of 110 cases of SMARCA4-deficient conventional non-small cell lung cancer.
Journal: Annals of diagnostic pathology
Published: July 16, 2026
Predictive value of Ki-67 expression in predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy in lung squamous cell carcinoma.
Journal: Frontiers in oncology
Published: April 18, 2026
Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression.
Journal: Frontiers in oncology
Published: April 01, 2026
High Efficacy of Chemoimmunotherapy in Advanced ALK-Rearranged Lung Squamous Cell Carcinoma: A Case Report.
Journal: Cancer management and research
Published: December 24, 2025
Clinicopathological and Genomic Analysis of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Retrospective Cohort Study.
Journal: Cancer management and research
Published: September 24, 2025
Combination of Aumolertinib, Dabrafenib, and Trametinib for a Patient with Advanced Lung Adenocarcinoma with an Osimertinib-Induced BRAF V600E Mutation: A Case Report.
Journal: OncoTargets and therapy
Published: January 10, 2025
Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report.
Journal: Cancer management and research
Published: May 18, 2023
Prognostic Value of Ki-67 Expression in Advanced Lung Squamous Cell Carcinoma Patients Treated with Chemotherapy.
Journal: Cancer management and research
Published: June 25, 2021
Analysis of the relationship between Ki-67 expression and chemotherapy and prognosis in advanced non-small cell lung cancer.
Journal: Translational cancer research
Published: October 01, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026